Prostate Cancer and the Hypofractionation Hypothesis
Author:
- 1 November 2013
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (31) , 3849-3851
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate CancerJournal of Clinical Oncology, 2013
- Whole-Pelvic Nodal Radiation Therapy in the Context of Hypofractionation for High-Risk Prostate Cancer Patients: A Step ForwardInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Hypofractionated Radiation Therapy (66 Gy in 22 Fractions at 3 Gy per Fraction) for Favorable-Risk Prostate Cancer: Long-term OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Hypofractionation for Clinically Localized Prostate CancerSeminars in Radiation Oncology, 2013
- Meta-analysis of the Alpha/Beta Ratio for Prostate Cancer in the Presence of an Overall Time Factor: Bad News, Good News, or No News?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Reporting of Noninferiority and Equivalence Randomized TrialsJAMA, 2012
- Hypofractionated Intensity-Modulated Radiotherapy (70 Gy at 2.5 Gy Per Fraction) for Localized Prostate Cancer: Cleveland Clinic ExperienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Fractionation and protraction for radiotherapy of prostate carcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- The Linear-Quadratic Model and Most Other Common Radiobiological Models Result in Similar Predictions of Time-Dose RelationshipsRadiation Research, 1998
- Time-dose factors in radiotherapy: a review of the human dataRadiotherapy and Oncology, 1990